Results 11 to 20 of about 854,306 (293)

Interferon-gamma in leishmaniasis. [PDF]

Frontiers in Immunology, 2013
Leishmaniasis is a complex disease that is caused by parasites of the Leishmania genus. Leishmania are further classified into several complexes, each of which can engage in distinct interactions with mammalian hosts resulting in differing disease ...
Peter Epeh Kima, Lynn eSoong
doaj   +3 more sources

The role of interferon-gamma and interferon-gamma receptor in tuberculosis and nontuberculous mycobacterial infections

International Journal of Mycobacteriology, 2021
Mycobacterium tuberculosis (Mtb) and nontuberculous mycobacteria (NTM) remain the leading causes of lung disease and mortality worldwide. Interferon-gamma (IFN-γ) and its receptor (IFN-γR) play a key role in mediating immunity against Mtb and NTM.
Jalaledin Ghanavi, Poopak Farnia, Parissa Farnia, Ali Akbar Velayati   +3 more
doaj   +3 more sources

Interferon-Gamma-Mediated Osteoimmunology [PDF]

Frontiers in Immunology, 2018
Osteoimmunology is the interdiscipline that focuses on the relationship between the skeletal and immune systems. They are interconnected by shared signal pathways and cytokines.
Mengjia Tang, Li Tian, Guojing Luo, Xijie Yu   +3 more
doaj   +3 more sources

Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands [PDF]

, 1992
Cytomegalovirus (CMV), similar to other members of the Herpesviridae family, can establish both persistent and latent infections. Each of the CMVs that are found in many animal species replicates in the salivary gland, and oral secretion represents a ...
Pavic, Ivica, Koszinowski, Ulrich H., Koszinowski, U H, Lucin, Pero, Polic, Bojan, Jonjic, Stipan   +5 more
core   +2 more sources

Interferon-Gamma

Mustansiriya Medical Journal, 2022
Background: Acromegaly is a rare endocrine disease, its incidence is 4-6 per million per years while its prevalence is 40-60 per million. The distinctive facial characteristics are prognathism prominent forehead, and large hands and feet. This happens after the fusion of growth plates; separating acromegaly from
Sabreen Hamodi Hamza, Zainab Fadhel Ashoor, Abbas Mahdi Rahmah   +2 more
openaire   +1 more source

Flow cytometric detection of gamma interferon can effectively discriminate Mycobacterium bovis BCG-vaccinated cattle from M. bovis-infected cattle [PDF]

, 2006
Mycobacterium bovis is the causative agent of bovine tuberculosis, a disease that is increasing in incidence in United Kingdom cattle herds. In addition to increasing economic losses, the rise in bovine tuberculosis poses a human health risk. There is an
C. J. Howard, Howard, C J, Hope, J C; id_orcid, P. Sopp, J. C. Hope, Sopp, P   +5 more
core   +1 more source

Interferon-gamma: A Review

Immunobiology, 1989
Article de synthese sur l'interferon gamma: role physiologique et utilisation therapeutique ...
Ijzermans, Jan N.M., Marquet, Richard L.
openaire   +3 more sources

Bovine NK cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70 [PDF]

, 2005
Bovine NK cells have recently been characterized and the present study describes the interaction between NK cells, antigen-presenting cells, and secreted mycobacteriall proteins.
Jungersen, Gregers, Anne K. Storset, Kulberg, Siri, Kulberg, S., Preben Boysen, Boysen, Preben, Jayne C. Hope, Siri Kulberg, Ingrid Olsen, Boysen, P., Storset, Anne K., Olsen, Ingrid, Storset, A.K., Hope, J.C., Gregers Jungersen, Hope, Jayne; id_orcid   +15 more
core   +1 more source

1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation [PDF]

, 2005
peer reviewed1alpha,25-Dihydroxyvitamin D3 (1alpha,25(OH)2D3), the activated vitamin D3 hormone, is a key regulator of calcium homeostasis and thereby indispensable for bone metabolism.
Frahm, Thomas, Ehrchen, Jan, Lengeling, Andreas, Helming, Laura, Geffers, Robert, Probst-Kepper, Michael, Schiebe, Stefanie, L. Helming, Böse, Jens, Balling, Rudi   +9 more
core   +1 more source

Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019
Background Tuberculosis screening is recommended in multiple sclerosis patients starting certain disease-modifying therapies. Disease-modifying therapies may affect interferon-gamma release assay results.
Laura E Baldassari, Jenny Feng, Gabrielle Macaron, Sarah M Planchon, Ebtesam Alshehri, Brandon P Moss, Daniel Ontaneda, Mary A Willis   +7 more
doaj   +1 more source